Product
ThermoDox
3 clinical trials
5 indications
Indication
Colorectal Cancer with Liver MetastasisIndication
Hepatocellular CarcinomaIndication
Pancreatic Ductal AdenocarcinomaIndication
Pancreatic CancerIndication
Pancreatic Cancer MetastaticClinical trial
Phase II Open Label Trial of Thermal Ablation and Lyso-Thermosensitive Liposomal Doxorubicin (Thermodox) for Metastatic Colorectal Cancer (mCRC) Liver LesionsStatus: Terminated, Estimated PCD: 2013-05-01
Clinical trial
A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDox® (Thermally Sensitive Liposomal Doxorubicin) in Combination With Radiofrequency Ablation (RFA) Compared to RFA-Alone in the Treatment of Non-Resectable Hepatocellular CarcinomaStatus: Completed, Estimated PCD: 2013-01-01
Clinical trial
PanDox: Feasibility of Enhanced Chemotherapy Delivery to Non-resectable Primary Pancreatic Tumours Using Thermosensitive Liposomal Doxorubicin (ThermoDox®) and Focused UltrasoundStatus: Withdrawn, Estimated PCD: 2023-03-30